Gina Consylman
2018 - Ironwood Pharmaceuticals
Compensation breakdown
Non-Equity Incentive Plan | $207,500 |
---|---|
Option Awards | $501,764 |
Salary | $415,000 |
Stock Awards | $782,385 |
Other | $8,040 |
Total | $1,914,689 |
Consylman received $782.4K in stock awards, accounting for 41% of the total pay in 2018.
Consylman also received $207.5K in non-equity incentive plan, $501.8K in option awards, $415K in salary and $8K in other compensation.
Rankings
In 2018, Gina Consylman's compensation ranked 5,968th out of 14,244 executives tracked by ExecPay. In other words, Consylman earned more than 58.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,968 | 58th |
Manufacturing | 2,270 | 61st |
Chemicals And Allied Products | 849 | 60th |
Drugs | 710 | 61st |
Pharmaceutical Preparations | 553 | 60th |
Consylman's colleagues
We found five more compensation records of executives who worked with Gina Consylman at Ironwood Pharmaceuticals in 2018.
2018
Peter Hecht
Ironwood Pharmaceuticals
Chief Executive Officer
2018
William Huyett
Ironwood Pharmaceuticals
Chief Operating Officer
2018
Mark Currie
Ironwood Pharmaceuticals
Chief Scientific Officer
2018
Thomas McCourt
Ironwood Pharmaceuticals
President
2018
Halley Gilbert
Ironwood Pharmaceuticals
Chief Administrative Officer
News
May 2, 2022
April 21, 2022
April 22, 2021
April 21, 2020
April 26, 2019